Blanchard Cheryl R (CIK 1326530) reported 9 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-03-17). Recent activity: Buy ANIK (24,519 shares), Buy ANIK (24,520 shares), Sell ANIK (14,728 shares), Buy ANIK (25,131 shares), Sell ANIK (12,104 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-17 | Anika Therapeutics, Inc. (ANIK) | Director | Buy | 24,519 | $0 |
| 2026-03-17 | Anika Therapeutics, Inc. (ANIK) | Director | Buy | 24,520 | $0 |
| 2026-03-17 | Anika Therapeutics, Inc. (ANIK) | Director | Sell | 14,728 | $209,138 |
| 2026-03-17 | Anika Therapeutics, Inc. (ANIK) | Director | Buy | 25,131 | $0 |
| 2026-03-17 | Anika Therapeutics, Inc. (ANIK) | Director | Sell | 12,104 | $171,877 |
| 2026-03-11 | Anika Therapeutics, Inc. (ANIK) | Director | Buy | 20,001 | $0 |
| 2026-03-11 | Anika Therapeutics, Inc. (ANIK) | Director | Sell | 5,871 | $87,830 |
| 2025-08-05 | Vigil Neuroscience, Inc. (VIGL) | Director | Sell | 5,000 | $0 |
| 2025-05-23 | Vigil Neuroscience, Inc. (VIGL) | Director | Buy | 5,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-03-17